Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Cancer therapies that target DNA damage repair

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.01.11
Views: 6355

Prof Stephen Jackson - University of Cambridge, UK

Prof Stephen Jackson speaks to ecancertv about cancer treatments that target cells’ ability to repair DNA damage. Cells are constantly damaged by influences such as UV light and radiation and consequently have systems in place to repair this damage. Prof Jackson's group developed Olaparib, a drug that targets the PARP repair enzyme in BRCA mutation positive breast or ovarian cancers. Prof Jackson discusses the potential to develop additional drugs that will target different damage repair enzymes which could be used to treat other cancers and talks about the session he will be chairing on this subject at the 2010 NCRI meeting.

Related videos

follow us

Tobacco Dependence e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation